1. Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis. Issue 1 (December 2016) Authors: Sonesson, Christian; Johansson, Peter; Johnsson, Eva; Gause-Nilsson, Ingrid Journal: Cardiovascular diabetology Issue: Volume 15:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cover Image, Volume 22, Issue 7. Issue 7 (19th June 2020) Authors: Johansson, Lars; Hockings, Paul D.; Johnsson, Eva; Dronamraju, Nalina; Maaske, Jill; Garcia‐Sanchez, Ricardo; Wilding, John P. H. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 7(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes. (September 2015) Authors: Sjöström, C David; Johansson, Peter; Ptaszynska, Agata; List, James; Johnsson, Eva Journal: Diabetes & vascular disease research Issue: Volume 12:Number 5(2015:Sep.) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year. Issue 9 (31st May 2017) Authors: Lundkvist, Per; Pereira, Maria J.; Katsogiannos, Petros; Sjöström, C. David; Johnsson, Eva; Eriksson, Jan W. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 9(2017) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Issue 1 (26th September 2016) Authors: Lundkvist, Per; Sjöström, C. David; Amini, Sam; Pereira, Maria J.; Johnsson, Eva; Eriksson, Jan W. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 1(2017) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes. Issue 7 (9th March 2020) Authors: Johansson, Lars; Hockings, Paul D.; Johnsson, Eva; Dronamraju, Nalina; Maaske, Jill; Garcia‐Sanchez, Ricardo; Wilding, John P. H. Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 7(2020) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis. Issue 1 (March 2016) Authors: Yavin, Yshai; Mansfield, Traci; Ptaszynska, Agata; Johnsson, Kristina; Parikh, Shamik; Johnsson, Eva Journal: Diabetes therapy Issue: Volume 7:Issue 1(2016) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period. Issue 4 (22nd January 2016) Authors: Araki, Eiichi; Onishi, Yukiko; Asano, Michiko; Kim, Hyosung; Ekholm, Ella; Johnsson, Eva; Yajima, Toshitaka Journal: Journal of diabetes investigation Issue: Volume 7:Issue 4(2016:Aug.) Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial*: 达格列净治疗接受二甲双胍治疗失败的亚洲2型糖尿病患者的疗效和安全性:一项随机对照研究. (9th January 2016) Authors: Yang, Wenying; Han, Ping; Min, Kyung‐Wan; Wang, Bei; Mansfield, Traci; T'Joen, Caroline; Iqbal, Nayyar; Johnsson, Eva; Ptaszynska, Agata Journal: Journal of diabetes Issue: Volume 8:Number 6(2016:Nov.) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes. Issue 11 (16th July 2018) Authors: Müller‐Wieland, Dirk; Kellerer, Monika; Cypryk, Katarzyna; Skripova, Dasa; Rohwedder, Katja; Johnsson, Eva; Garcia‐Sanchez, Ricardo; Kurlyandskaya, Raisa; Sjöström, C. David; Jacob, Stephan; Seufert, Jochen; Dronamraju, Nalina; Csomós, Katalin Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 11(2018) Page Start: 2598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗